Reasons for rarity of Th17 cells in inflammatory sites of human disorders

Seminars in Immunology

Volumn 25, Issue 4, 2013, Pages 299-304

  Annunziato, Francesco ^a,b   Santarlasci, Veronica ^a   Maggi, Laura ^a   Cosmi, Lorenzo ^a,b   Liotta, Francesco ^a,b   Romagnani, Sergio ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b CAREGGI UNIVERSITY HOSPITAL   (Italy)

Author keywords

CD161; IL 4I1; RORC; Th1; Th17; Tob1

Indexed keywords

CATECHOL OXIDASE; CD161 ANTIGEN; CD3 ANTIGEN; CHEMOKINE RECEPTOR CCR6; INTERLEUKIN 12; INTERLEUKIN 17 RECEPTOR; INTERLEUKIN 2; INTERLEUKIN 4; RETINOIC ACID; RETINOID RELATED ORPHAN RECEPTOR GAMMA; T LYMPHOCYTE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA;

ANTIGEN EXPRESSION; AUTOREGULATION; CELL CYCLE ARREST; CELL CYCLE PROGRESSION; CELL EXPANSION; CELL PROLIFERATION; CELLULAR IMMUNITY; CYTOKINE PRODUCTION; DOWN REGULATION; GENE CONTROL; GENE INDUCTION; GENETIC CODE; HUMAN; INFLAMMATION; INTRACELLULAR SIGNALING; MOLECULAR DYNAMICS; NONHUMAN; PHENOTYPIC PLASTICITY; PROTEIN EXPRESSION; REVIEW; TH1 CELL; TH17 CELL; UPREGULATION;

CD161; IL-4I1; RORC; TH1; TH17; TOB1;

ANIMALS; HUMANS; INFLAMMATION; T-LYMPHOCYTE SUBSETS; TH17 CELLS;

EID: 84888859870     PISSN: 10445323     EISSN: 10963618     Source Type: Journal    
DOI: 10.1016/j.smim.2013.10.011     Document Type: Review

References (42)

1. Mosmann T.R., Coffman R.L. TH1 And TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 1989, 7:145-173.
2. Romagnani S. Lymphokine production by human T cells in disease states. Annu Rev Immunol 1994, 12:227-257.
3. Harrington L.E., Hatton R.D., Mangan P.R., Turner H., Murphy T.L., Murphy K.M., et al. Interleukin-17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol 2005, 5:1123-1132.
4. Park H., Li Z., Yang X.O., Chang S.H., Nurieva R., Wang Y.H., et al. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol 2005, 5:1133-1141.
5. Cosmi L., De Palma R., Santarlasci V., Maggi L., Capone M., Frosali F., et al. Human interleukin 17-producing cells originate from a CD161+CD4+ T cell precursor. J Exp Med 2008, 205:1903-1916.
6. Pelletier M., Maggi L., Micheletti A., Lazzeri E., Tamassia N., Costantini C., et al. Evidence for a cross-talk between human neutrophils and Th17 cells. Blood 2010, 115:335-343.
7. Bettelli E., Carrier Y., Gao W., Korn T., Strom T.B., Oukka M., et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 2006, 441:235-238.
8. Acosta-Rodriguez E.V., Napolitani G., Lanzavecchia A., Sallusto Interleukins 1beta and 6 but not transforming growth factor-beta are essential for the differentiation of interleukin 17-producing human T helper cells. Nat Immunol 2007, 8:942-949.
9. Wilson N.J., Boniface K., Chan J.R., McKenzie B.S., Blumenschein W.M., Mattson J.D., et al. Development, cytokine profile and function of human interleukin 17-producing helper T cells. Nat Immunol 2007, 8:950-957.
10. van Beelen A.J., Zelinkova Z.Z., Taanman-Kueter E.W., Muller F.J., Hommes D.W., Zaat S.A.J., et al. Stimulation of the intracellular bacterial sensor NOD2 programs dendritic cells to promote interleukin-17 production in human memory T cells. Immunity 2007, 27:1-10.
11. Chung Y., Chang S.H., Martinez G.J., Yang X.O., Nurieva R., Kang H.S., et al. Critical regulation of early Th17 cell differentiation by interleukin-1 signaling. Immunity 2009, 30:576-587.
12. Ghoreschi K., Laurence A., Yang X.P., Tato C.M., McGeachy M.J., Konkel J.E., et al. Generation of pathogenic T(H)17 cells in the absence of TGF-β signalling. Nature 2010, 467:967-971.
13. Zielinski C.E., Mele F., Aschenbrenner D., Jarrossay D., Ronchi F., Gattorno M., et al. Pathogen-induced human T(H)17 cells produce IFN-γ or IL-10 and are regulated by IL-1β. Nature 2012, 484:514-518.
14. Murphy C.A., Langrish C.L., Chen Y., Blumenschein W., McClanahan T., Kastelein R.A., et al. Divergent pro- and antiinflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation. J Exp Med 2003, 198:1951-1957.
15. Langrish C.L., Chen Y., Blumenschein W.M., Mattson J., Basham B., Sedgwick J.D., et al. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J Exp Med 2005, 201:233-240.
16. Chen Y., Langrish C.L., McKenzie B., Joyce-Shaikh B., Stumhofer J.S., McClanahan T., et al. Anti-IL-23 therapy inhibits multiple inflammatory pathways and ameliorates autoimmune encephalomyelitis. J Clin Invest 2006, 116:1317-1326.
17. Annunziato F., Cosmi L., Santarlasci V., Maggi L., Liotta F., Mazzinghi B., et al. Phenotypic and functional features of human Th17 cells. J Exp Med 2007, 204:1849-1861.
18. Cosmi L., Cimaz R., Maggi L., Santarlasci V., Capone M., Borriello F., et al. Evidence of the transient nature of the Th17 phenotype of CD4+CD161+ T cells in the synovial fluid of patients with juvenile idiopathic arthritis. Arthritis Rheum 2011, 63:2504-2515.
19. Cosmi L., Maggi L., Santarlasci V., Capone M., Cardilicchia E., Frosali F., et al. Identification of a novel subset of human circulating memory CD4(+) T cells that produce both IL-17A and IL-4. J Allergy Clin Immunol 2010, 125:222-230.
20. Santarlasci V., Maggi L., Capone M., Querci V., Beltrame L., Cavalieri D., et al. Rarity of human T helper 17 cells is due to retinoic acid orphan receptor-dependent mechanisms that limit their expansion. Immunity 2012, 36:201-214.
21. Chu C.C., Paul W.E. Expressed genes in interleukin-4 treated B cells identified by cDNA representational difference analysis. Mol Immunol 1998, 35:487-502.
22. Boulland M.L., Marquet J., Molinier-Frenkel V., Möller P., Guiter C., Lasoudris F., et al. Human IL4I1 is a secreted l-phenylalanine oxidase expressed by mature dendritic cells that inhibits T-lymphocyte proliferation. Blood 2007, 110:220-227.
23. Tzachanis D., Freeman G.J., Hirano N., van Puijenbroek A.A., Delfs M.W., Berezovskaya A., et al. Tob is a negative regulator of activation that is expressed in anergic and quiescent T cells. Nat Immunol 2001, 2:1174-1182.
24. Hiramatsu Y., Kitagawa K., Suzuki T., Uchida C., Hattori T., Kikuchi H., et al. Degradation of Tob1 mediated by SCFSkp2-dependent ubiquitination. Cancer Res 2006, 66:8477-8483.
25. Huang H., Regan K.M., Wang F., Wang D., Smith D.I., van Deursen J.M., et al. Skp2 inhibits FOXO1 in tumor suppression through ubiquitin-mediated degradation. Proc Natl Acad Sci U S A 2005, 102:1649-1654.
26. Oh H.M., Yu C.R., Golestaneh N., Amadi-Obi A., Lee Y.S., Eseonu A., et al. STAT3 protein promotes T-cell survival and inhibits interleukin-2 production through up-regulation of Class O forkhead transcription factors. J Biol Chem 2011, 286:30888-30897.
27. Corvol J.C., Pelletier D., Henry R.G., Caillier S.J., Wang J., Pappas D., et al. Abrogation of T cell quiescence characterizes patients at high risk for multiple sclerosis after the initial neurological event. Proc Natl Acad Sci U S A 2008, 105:11839-11844.
28. Schulze-Topphoff U., Casazza S., Varrin-Doyer M., Michel K., Sobel R.A., Hauser S.L., et al. Tob1 plays a critical role in the activation of encephalitogenic T cells in CNS autoimmunity. J Exp Med 2013, 210:1301-1309.
29. Parronchi P., Romagnani P., Annunziato F., Sampognaro S., Becchio A., Giannarini L., et al. Type 1 T-helper cell predominance and interleukin-12 expression in the gut of patients with Crohn's disease. Am J Pathol 1997, 150:823-832.
30. Murphy K.M., Stockinger B. Effector T cell plasticity: flexibility in the face of changing circumstances. Nat Immunol 2010, 11:674-680.
31. Maggi L., Santarlasci V., Capone M., Rossi M.C., Querci V., Mazzoni A., et al. Distinctive features of classic and nonclassic (Th17 derived) human Th1 cells. Eur J Immunol 2012, 42:3180-3188.
32. Annunziato F., Cosmi L., Liotta F., Maggi E., Romagnani S. Defining the human T helper 17 cell phenotype. Trends Immunol 2012, 33:505-512.
33. Muranski P., Borman Z.A., Kerkar S.P., Klebanoff C.A., Ji Y., Sanchez-Perez L., et al. Th17 cells are long lived and retain a stem cell-like molecular signature. Immunity 2011, 35:972-985.
34. Kroenke M.A., Carlson T.J., Andjelkovic A.V., Segal B.M. IL-12- and IL-23-modulated T cells induce distinct types of EAE based on histology, CNS chemokine profile, and response to cytokine inhibition. J Exp Med 2008, 205:1535-1541.
35. Doodes P.D., Cao Y., Hamel K.M., Wang Y., Farkas B., Iwakura Y., et al. Development of proteoglycan-induced arthritis is independent of IL-17. J Immunol 2008, 181:329-337.
36. Luger D., Silver P.B., Tang J., Cua D., Chen Z., Iwakura Y., et al. Either a Th17 or a Th1 effector response can drive autoimmunity: conditions of disease induction affect dominant effector category. J Exp Med 2008, 205:799-810.
37. Haak S., Croxford A.L., Kreymborg K., Heppner F.L., Pouly S., Becher B., et al. IL-17A and IL-17F do not contribute vitally to autoimmune neuro-inflammation in mice. J Clin Invest 2009, 119:61-69.
38. Martin-Orozco N., Chung Y., Chang S.H., Wang Y.H., Dong C. Th17 cells promote pancreatic inflammation but only induce diabetes efficiently in lymphopenic hosts after conversion into Th1 cells. Eur J Immunol 2009, 39:216-224.
39. Bending D., et al. Highly purified Th17 cells from BDC2.5NOD mice convert into Th1-like cells in NOD/SCID recipient mice. J Clin Invest 2009, 119:565-572.
40. Duhen R., Glatigny S., Arbelaez C.A., Blair T.C., Oukka M., Bettelli E. Cutting Edge: the pathogenicity of IFN-γ-producing Th17 cells is independent of T-bet. J Immunol 2013, 190:4478-4482.
41. O'Connor R.A., Cambrook H., Huettner K., Anderton S.M. T-bet is essential for Th1-mediated, but not Th17-mediated, CNS autoimmune disease. Eur J Immunol 2013, July. 10.1002/eji.201343689.
42. Grifka-Walk H.M., Lalor S.J., Segal B.M. Highly polarized Th17 cells induce EAE via a T-bet independent mechanism. Eur J Immunol 2013, (July). 10.1002/eji.201343723.